Opportunity Information: Apply for RFA CA 20 055

The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) is a National Cancer Institute (NCI), NIH grant program meant to help exceptional early-stage postdoctoral researchers move efficiently from mentored training into fully independent, faculty-level research careers. The central goal is to grow and sustain a strong pipeline of new, talented, NCI-supported investigators by giving them structured support during the critical period when they are finishing postdoctoral work and competing for tenure-track (or equivalent) positions. A key feature of this specific opportunity is that it is the K99/R00 version that requires independent basic experimental studies with humans, meaning the proposed research is expected to involve human participants or human-derived materials in a way that fits NIH definitions for human subjects research in basic experimental contexts.

This award targets postdoctoral fellows who already have a research doctoral degree and/or a clinical doctoral degree and who are ready for independence without needing many additional years of mentored training beyond the doctorate. In practical terms, it is designed for people who can credibly make the jump to leading their own lab or independent research program on a relatively short timeline, but who would benefit from a funding mechanism that bridges the last phase of postdoctoral development and the early years of a faculty appointment. The program is structured to encourage a timely transition by pairing a mentored phase (the K99 portion) with a subsequent independent phase (the R00 portion), with the expectation that the awardee will secure an independent, tenure-track or equivalent research position to activate the R00 support.

NCI positions this mechanism as both a career development and research support tool. During the transition, the award provides NCI-backed resources that are intended to help recipients publish, build a distinct scientific niche, and establish the early track record needed to compete successfully for longer-term independent NIH funding. While the broad focus is aligned with NCI priorities in cancer research, the notice also explicitly highlights that applicants working in data science and cancer control science are especially encouraged to apply, signaling particular interest in research that strengthens computational, analytical, population-level, implementation, prevention, behavioral, outcomes, or related approaches that can improve cancer-related knowledge and public health impact.

From an eligibility standpoint, the opportunity is offered as a discretionary grant under NIH (AgencyName: National Institutes of Health) and is associated with CFDA number 93.398. Eligible applicant organizations are broad and include many types of U.S. public and private entities: state, county, and local governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other eligible organizations. The announcement also calls out a range of institution types that NIH and NCI often aim to include and support, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations, regional organizations, eligible federal agencies, and certain tribal governments and tribal organizations (including some categories other than federally recognized tribal governments).

There are important geographic and foreign involvement rules spelled out in the listing. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are not eligible to apply. At the same time, foreign components are allowed as defined in the NIH Grants Policy Statement, which generally means a U.S. applicant may include certain well-justified elements of the work performed abroad or involving foreign collaborators, as long as NIH policy requirements are met and the overall application remains anchored in an eligible applicant organization.

The specific opportunity identifier for this grant is Funding Opportunity Number RFA-CA-20-055, with an original closing date of 2021-02-26 and a creation date of 2020-10-28. The listing does not specify an award ceiling or the expected number of awards in the provided source data, so applicants would typically rely on the full funding announcement and NIH guidance for budget limits, project period structure, and other administrative details. Overall, the program is best understood as an NCI-supported launchpad for postdoctoral researchers who are very close to independence and whose proposed cancer-relevant research, including required basic experimental studies involving humans, can form the foundation of a distinct and competitive independent research career.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
  • This funding opportunity was created on 2020-10-28.
  • Applicants must submit their applications by 2021-02-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 20 055

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: U.S. Mission to Indonesia Annual Program Statement

Previous opportunity: NEA Arts & Artifacts International Indemnity Program, FY2021

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 20 055

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 20 055) also looked into and applied for these:

Funding Opportunity
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) Apply for RFA CA 20 057

Funding Number: RFA CA 20 057
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Apply for PAR 21 035

Funding Number: PAR 21 035
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) Apply for PAR 21 033

Funding Number: PAR 21 033
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) Apply for PAR 21 023

Funding Number: PAR 21 023
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Apply for PAR 21 022

Funding Number: PAR 21 022
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R34 Clinical Trial Optional) Apply for RFA MH 21 150

Funding Number: RFA MH 21 150
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R01 Clinical Trial Optional) Apply for RFA MH 21 151

Funding Number: RFA MH 21 151
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) Apply for PAR 21 065

Funding Number: PAR 21 065
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) Apply for PAR 21 066

Funding Number: PAR 21 066
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) Apply for PAR 21 067

Funding Number: PAR 21 067
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) Apply for RFA CA 21 003

Funding Number: RFA CA 21 003
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) Apply for RFA CA 21 005

Funding Number: RFA CA 21 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 21 004

Funding Number: RFA CA 21 004
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 21 006

Funding Number: RFA CA 21 006
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) Apply for RFA CA 21 009

Funding Number: RFA CA 21 009
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 21 008

Funding Number: RFA CA 21 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 21 012

Funding Number: RFA CA 21 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 21 007

Funding Number: RFA CA 21 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 21 011

Funding Number: RFA CA 21 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Apply for RFA CA 21 010

Funding Number: RFA CA 21 010
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 20 055", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: